Instruction for use: Xylometazoline

Active substance: Xylometazoline

ATX Code R01AA07 Xylometazoline

Pharmacotherapeutic group:

Alpha-adrainomimetiki

decongestant

The nosological classification (ICD-10)

J00 Acute nasopharyngitis [runny nose]

Viral rhinitis, Inflammation of the nasopharynx, Inflammatory diseases of the nose, purulent rhinitis, Nasal congestion, Nasal congestion with colds and flu, The difficulty of nasal breathing, The difficulty of nasal breathing for colds, Difficulty in nasal breathing, Difficulty in nasal breathing in colds, nasal, hypersecretion, cold, ARI with rhinitis phenomena, coryza, Acute rhinitis of various origins, Acute rhinitis with thick purulent mucous exudate, Acute nasopharyngitis, Swelling of the mucosa of the nasopharynx, Rhinitis, rhinorrhea, Infectious-inflammatory diseases of ENT organs, heavy cold, rhinopharyngitis, nasopharyngitis

J01 Acute sinusitis

Inflammation of the sinuses, Inflammatory diseases of the paranasal sinuses, Purulent inflammation of the paranasal sinuses, Infectious-inflammatory diseases of ENT organs, Infection of the sinuses, Combined sinusitis, Exacerbation of sinusitis, Acute inflammation of the paranasal sinuses, Acute bacterial sinusitis, Acute sinusitis in adults, Subacute sinusitis, acute Sinusitis, sinusitis

J30 Vasomotor and allergic rhinitis

Allergic rinopatiya, Allergic rhinosinusopathy, Allergic respiratory diseases, Allergic rhinitis, nasal allergy, Seasonal Allergic Rhinitis, Vasomotor rhinitis, Long-allergic rhinitis, Perennial allergic rhinitis, Perennial allergic rhinitis, Year-round or seasonal allergic rhinitis, Year-round allergic rhinitis nature, Rhinitis allergic vasomotor, Exacerbation of pollen allergy in the form of Syndrome rinokonyunktivalnogo, Acute allergic rhinitis, Edema of the nasal mucosa, Edema of the nasal mucosa, Swelling of the mucosa of the nasal cavity, Swelling of the nasal mucosa, Swelling of the nasal mucosa, pollen disease, Permanent allergic rhinitis, rhinoconjunctivitis, rhinosinusitis,rhinosinusopathy, Seasonal allergic rhinitis, Seasonal Allergic Rhinitis, Haymarket rhinitis, Chronic allergic rhinitis, Allergic respiratory diseases

J32 Chronic sinusitis

Allergic rhinosinusopathy, purulent sinusitis, Catarrh nasopharyngeal area, Catarrh of the sinuses, Exacerbation of sinusitis, chronic Sinusitis

Composition

1 ml of gel for intranasal administration contains Xylometazoline 0.5 or 1 mg; in tubes of 5 g, 1 tube per box.

Pharmachologic effect
antikongestat

Excited alpha-adrenergic receptors of the blood vessels nasopharyngeal mucosa.

Clinical pharmacology

It reduces congestion and swelling of the nasal mucosa and the amount of discharge of secretions. Restore patency of the nasal passages in inflammatory and allergic conditions, facilitates nasal breathing. Peppermint oil has anti-inflammatory, analgesic and anti-bacterial action. The effect occurs within minutes after application and lasts for several hours.

Indications

Rhinitis (including acute allergic rhinitis), nasopharyngitis, sinusitis.

Contraindications

Hypersensitivity, dry and chronic rhinitis, glaucoma, diseases of the cardiovascular system.

Side effects

Dryness and burning sensation in the mucous membrane of the nose, headaches, insomnia, visual disturbances, arrhythmia, increased blood pressure.

Interaction

Drugs stimulating the sympathetic system, enhance the effect.

Xylometazoline Dosage and Administration

Intranasal 1 drop three times a day. Adults - Gel 0.1%, children - 0.05% gel.

Precautionary measures

Be wary appoint pregnant. Do not use for a long time. Protect your eyes from accidental contact with the drug.

Storage conditions of Xylometazoline

In a dry, dark place, at a temperature of 15-25 ° C.

Keep out of the reach of children.
Shelf life of Xylometazoline

3 years.

Do not use beyond the expiration date printed on the package.